NEW YORK – Shares of Bionano Genomics were up more than 40 percent in Wednesday afternoon trading after the company highlighted the results of a recently published preprint study demonstrating the superiority of its optical mapping technology for detecting large structural variations (SVs) in de novo sequencing data.